|
|
English
version
For å registrere i Cristin må du være vitenskapelig eller administrativt ansatt.
|
|
|
|
|
|
|
|
|
2019
|
1. |
Andersson, Yvonne; Inderberg, Else Marit; Kvalheim, Gunnar; Herud, Morten Theodor Malmer; Engebråten, Olav; Flatmark, Kjersti; Dueland, Svein; Fodstad, Øystein. Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients. Acta Oncologica 2019 s. 1-7 OUS OSTFSYK UiO
Untitled
|
|
2. |
Debik, Julia Barbara; Euceda, Leslie R.; Lundgren, Steinar; Gythfeldt, Hedda; Garred, Øystein; Borgen, Elin; Engebråten, Olav; Bathen, Tone Frost; Giskeødegård, Guro F.. Assessing treatment response and prognosis by serum and tissue metabolomics in breast cancer patients. Journal of Proteome Research 2019 ;Volum 18.(10) s. 3649-3660 NTNU STO OUS UiO
Untitled
|
|
3. |
Lai, Xiaoran; Geier, Oliver; Fleischer, Thomas; Garred, Øystein; Borgen, Elin; Funke, Simon Wolfgang; Kumar, Surendra; Rognes, Marie Elisabeth; Seierstad, Therese; Børresen-Dale, Anne-Lise; Kristensen, Vessela N.; Engebråten, Olav; Kohn Luque, Alvaro; Frigessi Di Rattalma, Arnoldo. Towards personalized computer simulation of breast cancer treatment: a multi-scale pharmacokinetic and pharmacodynamic model informed by multi-type patient data. Cancer Research 2019 ;Volum 79.(16) s. 4293-4304 AHUS UiO OUS
Untitled
|
|
4. |
Lindholm, Evita Maria; Aure, Miriam Ragle; Haugen, Mads Haugland; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Nebdal, Daniel J.H.; Børresen-Dale, Anne-Lise; Lingjærde, Ole Christian; Engebråten, Olav. miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology 2019 ;Volum 13.(10) s. 2278-2296 AHUS OUS VV UiO
Untitled
|
|
5. |
Nome, Marianne Eikhom; Euceda, Leslie R.; Jabeen, Shakila; Debik, Julia; Bathen, Tone Frost; Giskeødegård, Guro F.; Tasken, Kristin Austlid; Mælandsmo, Gunhild Mari; Halvorsen, Bente; Yndestad, Arne; Borgen, Elin; Garred, Øystein; Aukrust, Pål; Ueland, Thor; Engebråten, Olav; Kristensen, Vessela N.; Tekpli, Xavier. Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. International Journal of Cancer 2019 ;Volum 146.(1) s. 223-235 NTNU AHUS OUS UiO UiT
Untitled
|
|